Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoko Yamada

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Scientific Reports|September 18, 2020
Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activationYuto Shiode, Hayato Hikita, Satoshi Tanaka, et al.
Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.
Digestive Diseases and Sciences|March 30, 2022
Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or SmallerAtsuo Takigawa, Ryotaro Sakamori, Yuki Tahata, et al.
Plos One|June 17, 2020
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infectionNaoki Morishita, Ryotaro Sakamori, Tomomi Yamada, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2021
The First Transileocolic Obliteration for Refractory Esophageal Varices: A Case Report and Review of the LiteratureYoshifumi Fujii, Ryotaro Sakamori, Ryoko Yamada, et al.
The Journal of Clinical Investigation|May 25, 2021
Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulationTakeshi Tamura, Takahiro Kodama, Katsuhiko Sato, et al.
Frontiers in Veterinary Science|March 6, 2025
Comprehensive investigation of gene mutations in canine large cell gastrointestinal lymphomaNaoki Matsumura, Takumi Tsuruta, Yuko Goto-Koshino, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2020
Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertensionKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Digestive Diseases and Sciences|June 20, 2020
Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular CarcinomaTadashi Kegasawa, Ryotaro Sakamori, Kazuki Maesaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2021
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatmentKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Scientific Reports|September 18, 2020
Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activationYuto Shiode, Hayato Hikita, Satoshi Tanaka, et al.
Journal of Gastroenterology|January 27, 2019
Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver miceAkira Doi, Hayato Hikita, Yugo Kai, et al.
Digestive Diseases and Sciences|March 30, 2022
Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or SmallerAtsuo Takigawa, Ryotaro Sakamori, Yuki Tahata, et al.
Plos One|June 17, 2020
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infectionNaoki Morishita, Ryotaro Sakamori, Tomomi Yamada, et al.
Internal Medicine (Tokyo, Japan)|September 2, 2021
The First Transileocolic Obliteration for Refractory Esophageal Varices: A Case Report and Review of the LiteratureYoshifumi Fujii, Ryotaro Sakamori, Ryoko Yamada, et al.
The Journal of Clinical Investigation|May 25, 2021
Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulationTakeshi Tamura, Takahiro Kodama, Katsuhiko Sato, et al.
Frontiers in Veterinary Science|March 6, 2025
Comprehensive investigation of gene mutations in canine large cell gastrointestinal lymphomaNaoki Matsumura, Takumi Tsuruta, Yuko Goto-Koshino, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2020
Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertensionKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Digestive Diseases and Sciences|June 20, 2020
Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular CarcinomaTadashi Kegasawa, Ryotaro Sakamori, Kazuki Maesaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2021
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatmentKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Pageof 9